Skip to main content

Ben Kaplan, Joseph Keyes

Premium

Genaissance Pharmaceuticals has appointed Ben Kaplan senior vice president and chief financial officer. He succeeds Joseph Keyes, who is resigning as CFO to “pursue other interests.” Kaplan, 46, comes to Genaissance from a six-month stint as senior vice president for finance and administration and CFO at Ikonisys, a small diagnostic company. He was also a consultant to PerkinElmer, and was vice president and CFO at Packard Bioscience.

 

Filed under

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.